Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Other hematologic neoplasm 4Thoracic 3Myeloid 3Plasma cell 2Lymphoid 2Gastrointestinal 2Dermatologic 2CNS 2Sarcoma 1Other solid neoplasm 1Other 1Head & Neck 1Gynecologic 1

Conditions

Mucositis 17Pain 12Opioid-Induced Constipation 12Constipation 12Obesity 11Sexual Dysfunction, Physiological 9Head and Neck Neoplasms 8Neoplasms 7Breast Neoplasms 7Polycystic Ovary Syndrome 4Bronchiolitis Obliterans Syndrome 4Weight Loss 3Prostatic Neoplasms 3Intestinal Diseases 3Stomatitis 2Squamous Cell Carcinoma of Head and Neck 2Sexuality 2Prediabetic State 2Intestinal Obstruction 2Hyperinsulinism 2Fatigue 2Dyspnea 2Xerostomia 1Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urinary Incontinence 1Tongue Neoplasms 1Testicular Neoplasms 1

Interventions

Dehydroepiandrosterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Depression × Other × Clear all
NCT01376349 2019-02-07

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Alliance for Clinical Trials in Oncology

Phase 3 Completed
464 enrolled 8 charts
BreastGynecologicOther

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Sexual Dysfunction, Physiological, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡